Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1366

1.

Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.

Van den Bosch GA, Van Gulck E, Ponsaerts P, Nijs G, Lenjou M, Apers L, Kint I, Heyndrickx L, Vanham G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF.

J Immunother. 2006 Sep-Oct;29(5):512-23.

PMID:
16971807
2.

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.

Van Gulck ER, Ponsaerts P, Heyndrickx L, Vereecken K, Moerman F, De Roo A, Colebunders R, Van den Bosch G, Van Bockstaele DR, Van Tendeloo VF, Allard S, Verrier B, Marañón C, Hoeffel G, Hosmalin A, Berneman ZN, Vanham G.

Blood. 2006 Mar 1;107(5):1818-27. Epub 2005 Nov 1.

3.

Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.

Van den Bosch GA, Ponsaerts P, Nijs G, Lenjou M, Vanham G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF.

Clin Exp Immunol. 2005 Mar;139(3):458-67.

4.

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.

J Infect Dis. 2001 Aug 1;184(3):256-67. Epub 2001 Jul 10.

5.

Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein.

Carlsson B, Hou M, Giandomenico V, Nilsson B, Totterman TH, Essand M.

J Infect Dis. 2005 Dec 1;192(11):1912-20. Epub 2005 Oct 21.

6.

Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.

Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP Jr, Keyvanfar K, Barrett AJ.

J Immunother. 2006 Jul-Aug;29(4):436-43; discussion 365-6.

PMID:
16799339
7.

Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.

Van Gulck ER, Vanham G, Heyndrickx L, Coppens S, Vereecken K, Atkinson D, Florence E, Kint I, Berneman ZN, Van Tendeloo V.

J Virol. 2008 Apr;82(7):3561-73. doi: 10.1128/JVI.02080-07. Epub 2008 Jan 30.

8.

Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children.

Bekker V, Bronke C, Scherpbier HJ, Weel JF, Jurriaans S, Wertheim-van Dillen PM, van Leth F, Lange JM, Tesselaar K, van Baarle D, Kuijpers TW.

AIDS. 2005 Jul 1;19(10):1025-34.

PMID:
15958833
9.
10.

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.

Van Gulck E, Vlieghe E, Vekemans M, Van Tendeloo VF, Van De Velde A, Smits E, Anguille S, Cools N, Goossens H, Mertens L, De Haes W, Wong J, Florence E, Vanham G, Berneman ZN.

AIDS. 2012 Feb 20;26(4):F1-12. doi: 10.1097/QAD.0b013e32834f33e8.

PMID:
22156965
11.

Rapid generation of CMV pp65-specific T cells for immunotherapy.

Bao L, Sun Q, Lucas KG.

J Immunother. 2007 Jul-Aug;30(5):557-61.

PMID:
17589296
12.
13.

Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.

Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.

Cytometry B Clin Cytom. 2008 Jul;74(4):211-20. doi: 10.1002/cyto.b.20420.

14.

Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.

Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.

J Infect Dis. 2005 Mar 15;191(6):873-80. Epub 2005 Jan 31.

15.

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection.

Zaunders JJ, Dyer WB, Wang B, Munier ML, Miranda-Saksena M, Newton R, Moore J, Mackay CR, Cooper DA, Saksena NK, Kelleher AD.

Blood. 2004 Mar 15;103(6):2238-47. Epub 2003 Nov 26.

16.

Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.

Komanduri KV, Donahoe SM, Moretto WJ, Schmidt DK, Gillespie G, Ogg GS, Roederer M, Nixon DF, McCune JM.

Virology. 2001 Jan 20;279(2):459-70.

17.

RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells.

Shen SN, Xu Z, Qian XP, Ding YT, Yu LX, Liu BR.

Eur J Cancer Care (Engl). 2008 Jul;17(4):404-11. doi: 10.1111/j.1365-2354.2007.00841.x.

PMID:
18485013
18.

Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.

Melhem NM, Liu XD, Boczkowski D, Gilboa E, Barratt-Boyes SM.

Eur J Immunol. 2007 Aug;37(8):2164-73.

19.

Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation.

Foster AE, Gottlieb DJ, Sartor M, Hertzberg MS, Bradstock KF.

Biol Blood Marrow Transplant. 2002;8(9):501-11.

PMID:
12374455
20.

Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.

Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, Lieberman J.

Blood. 2000 Nov 1;96(9):3094-101.

Items per page

Supplemental Content

Write to the Help Desk